English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIt was a rare blessing of the early pandemic: Children seemed to be mostly spared from the effects of COVID-19. But in March and April 2020, doctors in Italy, followed by clinicians around the world, began observing cases of young children with a serious new inflammatory syndrome.
Tag: Multisystem Inflammatory Syndrome in Children (MIS-C)
Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection
New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease.
The findings, published in Science, are the first potential genetic cause identified for MIS-C, a disease that typically occurs about four weeks after COVID-19 infection and has broad symptoms such as fever, vomiting and inflammation of the heart muscle that can lead to hospitalization. States have reported about 9,000 MIS-C cases, with 71 deaths, according to most recent Centers for Disease Control and Prevention numbers.
Substantial proportion of ethnically diverse children from low-resource backgrounds report long-term COVID-19 complications
A substantial proportion of ethnically diverse children from low-resource backgrounds with severe COVID-19 illness are reporting long-term complications from the virus, according to research from UTHealth Houston.
MEDIA ADVISORY: AAP 2022 to Feature Cedars-Sinai Guerin Children’s Clinicians and Researchers
Cedars-Sinai Guerin Children’s pediatric specialists will share their expertise and recent research findings at the American Academy of Pediatrics Annual Meeting, taking place Oct. 7-11 in Anaheim, California.
Hyperactivation of the Immune System May Cause Post-COVID Syndromes
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.